We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Exercise Intensity and Type 2 Diabetics (EIT2D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01356953
Recruitment Status : Completed
First Posted : May 20, 2011
Last Update Posted : May 20, 2011
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine if a single session of aerobic exercise effectively controls the blood pressure (BP) of individuals with type 2 diabetes mellitus (T2DM) over the 24h of post-exercise period, and the effects of intensity of aerobic exercise on these BP responses.

Condition or disease Intervention/treatment
Type 2 Diabetes Other: Aerobic exercise

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Exercise Intensity on 24-h Ambulatory Blood Pressure in Type 2 Diabetics
Study Start Date : October 2008
Primary Completion Date : July 2009
Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Aerobic Exercise Other: Aerobic exercise
Intensity of aerobic exercise

Outcome Measures

Primary Outcome Measures :
  1. Blood Pressure - Ambulatory blood pressure monitoring (ABPM) [ Time Frame: Participants will be followed for the duration of experimental tests, an expected average of 4 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   45 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • sedentary
  • a diagnosis of T2DM for at least one year
  • glycemic control through nutrition and/or medication

Exclusion Criteria:

  • be not under use of exogenous insulin and do not present chronic complications such as diabetic foot
  • nephropathy
  • retinopathy
  • neuropathies and cardiovascular diseases
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01356953

Catholic University of Brasilia
Taguatinga, Brazil, 72030-170
Sponsors and Collaborators
Catholic University of Brasília
Conselho Nacional de Desenvolvimento Científico e Tecnológico
More Information

Responsible Party: Pâmella Karoline de Morais, Universidade Católica de Brasília
ClinicalTrials.gov Identifier: NCT01356953     History of Changes
Other Study ID Numbers: MORAIS0132008
First Posted: May 20, 2011    Key Record Dates
Last Update Posted: May 20, 2011
Last Verified: September 2008

Keywords provided by Catholic University of Brasília:
Aerobic Exercise
Blood Pressure